The novel treatment of this peptide represents a significant breakthrough in the care of type 2 diabetes. Different to existing medications, tirzepatide targets two pathways – GLP-1 and GIP – resulting in improved https://tirzepatidepeptide825034.blogitright.com/42355652/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment